HKU Scholars Hub: Browsing DSpace

Browsing by Author McClure, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 7 of 7

	Title	Author(s)	Issue Date
	Prolonged ( > 24 Week) Dosing With The Oral Cam- E Compound Alg-000184 Results In Multi- Log Reductions In Hepatitis B Surface Antigen, Hbv Dna, And Hbv Rna Levels In Untreated E Antigen Positive Subjects With Chronic Hepatitis B Journal:Hepatology	Hou, JL Ding, YH Liang, XE Xu, J Yuen, MF Gane, EJ Agarwal, K Niu, JQ Wu, M Le, K Westland, C Maderazo, M Harrington, G Blatt, LM Beigelman, LN Chanda, S Lin, TI McClure, M	31-Oct-2023
	Safety, pharmacokinetics (PK), and antiviral activity of the capsid assembly modulator (CAM) ALG-000184 in Asian and non-Asian subjects with chronic hepatitis B (CHB) Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Yuen, RMF Agarwal, K Gane, E Jucov, A Schwabe, C Le, K Massetto, B Westland, C Zhang, QL Blatt, L Lin, T-I Chanda, S Mcclure, M Fry, J	2022
	Safety, pharmacokinetics (PK), and antiviral activity of the capsid assembly modulator (CAM) ALG-000184 in subjects with chronic hepatitis B (CHB) Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Gane, EJ Yuen, RMF Jucov, A Le, K Westland, C Schwabe, C Agarwal, K Zhang, QL Blatt, LM Chanda, S McClure, M Fry, J	2021
	Safety, pharmacokinetics, and antiviral activity of the S-antigen Transport Inhibiting Oligonucleotide Polymers (STOPS) drug candidate ALG-010133 in subjects with chronic hepatitis B. Poster Presentation (SAT435) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Gane, EJ Agarwal, K Yuen, RMF Jucov, A Schwabe, C Le, K Wang, S Westland, C Steel, K Zhang, QL Gohil, V Lai, F Venkatraman, M Blatt, L Beigelman, L Lin, T-I Chanda, S McClure, M Fry, J	2022
	Safety, tolerability and pharmacokinetics (pk) of single and multiple doses of alg-010133, an s-antigen transport inhibiting oligonucleotide polymer (stops) for the treatment of chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Gane, E Yuen, RMF Yogaratnam, J Le, K Vuong, J Christopher, W Gohil, V Schwabe, C Agarwal, K Jucov, A Liu, JW Lin, T-I Blatt, L Chanda, S McClure, M Fry, J	2021
	Safety, tolerability and pharmacokinetics of single ascending doses of ALG-020572, a GalNAc-conjugated antisense oligonucleotide, in healthy subjects. Poster Presentation (SAT343) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Gane, EH Yuen, RMF Schwabe, C Wu, M Le, K Rito, J Gupta, K Westland, C Lai, F Venkatraman, M Fitzgerald, M Lin, T-I Blatt, L Chanda, S McClure, M Fry, J Agarwal, K	2022
	The Capsid Assembly Modulator ALG-000184 dosed for 28 days was well tolerated and rapidly reduced viral markers in subjects with chronic hepatitis B, including HBsAg in a subset of HBeAg positive subjects with elevated baseline ALT Proceeding/Conference:Hepatology International	Gane, E Yuen, MF Agarwal, K Juov, A Hou, J Niu, J Massetto, B Le, K Lin, TI McClure, M	31-Mar-2023

Showing results 1 to 7 of 7